Express Pharma - Page 204 of 2207 - Express Pharma

Lessons from the Delhi–Agra–Puducherry counterfeit medicine investigation

Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell Therapy

The fine line between reform and risk

Biocon receives EIR with VAI status

Cobenfy could break dopamine dominance in schizophrenia treatment: GlobalData

Govt provides updates on measures to encourage domestic manufacturing

M&A in pharma sees deals worth $14.8 bn in Nov 2024

Piramal Pharma Solutions reaches settlement in legal dispute with VetDC

Lupin receives U.S. FDA tentative approval for HIV treatment generic

Life sciences CEOs optimistic about company growth amid industry challenges

Lupin Research Park R&D facility in Pune secures LEED Platinum Certification

One third of HCPs prioritise data privacy as the top challenge for AI in clinical practice: GlobalData

Antag Therapeutics secures €80 million Series A financing